BARCLAYS PLC - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 47 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$0
-100.0%
163
-96.9%
0.00%
Q1 2023$4
-98.3%
5,290
-98.8%
0.00%
Q4 2022$230
-99.9%
452,2500.0%0.00%
Q3 2022$289,000
-38.0%
452,2500.0%0.00%
Q2 2022$466,000
-45.9%
452,250
-1.2%
0.00%
-100.0%
Q1 2022$861,000457,9670.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders